Israel’s Teva and Japan’s Takeda are partnering to market Teva’s generic treatments and off-patent medicines in Japan. Japan’s aging population requires increased health care and Teva’s generic products can provide this at less cost.

http://www.bloomberg.com/news/articles/2015-11-30/takeda-teva-to-form-partnership-in-japan-for-generic-drug-sales